NeuroMetrix, Cyberkinetics to develop device for nerve injuries

11/14/2007 | American City Business Journals

NeuroMetrix has agreed to a joint venture with Cyberkinetics Neurotechnology Systems to develop a device for the treatment of peripheral nerve injuries. Under the deal, NeuroMetrix will invest $2 million for the development of the device for two years, with an opportunity to gain exclusive rights to the product once it reaches the market.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Counsel
Food and Drug Administration
Silver Spring, MD
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Vice President, Commercial Markets
Meridian Health
Neptune, NJ
Health Plan CEO – Oregon
Trillium Community Health Plan
Eugene, OR
Director of Operations - GBS
Mayo Clinic
Rochester, MN